Professor of Medicine Chief, Division of Cardiology & Co-Director Duke Heart Center – Duke Universit
I am an interventional cardiologist and Associate Professor of Medicine at the Duke University Medical Center and Duke Clinical Research Institute. My research interests include evaluating novel therapeutics for patients with coronary and peripheral vascular disease. At present, I serve as the Chief of the Division of Cardiology and Co-Director Duke University Health System. I have been integrally involved in conducting clinical trials and outcomes assessments of technologies and therapeutics aimed at patients with coronary and vascular disease. I was the principle Investigator for the Coordinating Center for the EUCLID trial, a 14,000 patient randomized trial comparing ticagrelor with clopidogrel for cardiovascular outcomes in patients with peripheral artery disease, site principle investigator of the PORTRIAT registry, a PCORI funded registry of patients with PAD and their reported symptoms, site principle investigator for SYPRAL, a 200 patient randomized trial evaluating renal denervation for hypertension patients, and principle investigator for ADVANCE, a 5000 patient registry evaluating the role of CT-FFR in patients with chest pain in practice. Beyond these current studies, I am involved in a group that has used administrative claims data, electronic health data, and registry data to understand the care patterns and outcome of patients with peripheral vascular disease. I am also working with several early phase companies aimed at developing devices or therapeutics for patients with vascular disease. On a national level, I am the Chair of the ACC Task Force for Appropriate Use and Chair of the AHA Diagnostic and Interventional Cath Committee. Clinically, I see and care for patients with coronary and vascular disease with a focus on both medical therapies and procedures to improve their outcomes.
Friday, October 25
4:40 PM – 4:45 PM